MedTrace Logo

Decision Support Tool for Gonadotrophin Dose Selection in ART.

NCT05811065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-12-07

No results posted yet for this study

Summary

A multi-center randomized clinical trial is proposed to study the effectiveness of the advanced decision support tool Opt-IVF in reducing medication, testing, and improving outcomes.

Conditions

  • IVF

Interventions

DEVICE

OPTIVF dosage

Opt-IVF dosage

DEVICE

traditional drug treament

Traditional drug treatment

Sponsors & Collaborators

  • Indira IVF, India

    collaborator UNKNOWN

  • Stochastic Research Technologies LLC

    lead INDUSTRY

Principal Investigators

  • Urmila Diwekar, Ph.D. · Stochastic Research Technologies LLC/University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2023-07-25
Completion
2023-07-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05811065 on ClinicalTrials.gov